The promise is straightforward: find cancers earlier, when treatment is often more effective and outcomes are generally ...
The American Cancer Society updated colorectal cancer screening guidelines, adding blood-based tests and reaffirming ...
About 50 million Americans aren’t getting screened for colon cancer at a time when colon-cancer rates are rising.
The study, published in the International Journal of Cancer, found that point-of-care tests have the potential to become ...
Scientists have identified a 14-protein blood signature that may predict lung cancer risk more than five years before ...
Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...
A new artificial intelligence-powered cancer detection tool is under review by the Food and Drug Administration and could ...
The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.The NHS-Galleri trial did not ...
A multicancer early detection (MCED) test was developed and validated in the case-control Circulating Cell-free Genome Atlas (CCGA) study (ClinicalTrials.gov identifier: NCT02889978). Previous ...
A new study by investigators from Mass General Brigham Cancer Institute found that an ultrasensitive blood test called ...